{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:45:38Z","timestamp":1790649938227,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","ashjournal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Society of Hypertension"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.jash.2017.12.002","type":"journal-article","created":{"date-parts":[[2017,12,14]],"date-time":"2017-12-14T08:23:55Z","timestamp":1513239835000},"page":"80-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Effects of orlistat on blood pressure: a systematic review and meta-analysis of 27 randomized controlled clinical trials"],"prefix":"10.1016","volume":"12","author":[{"given":"Amirhossein","family":"Sahebkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis E.","family":"Simental-Mend\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petri T.","family":"Kovanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Pedone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Simental-Mend\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4367-3884","authenticated-orcid":false,"given":"Arrigo F.G.","family":"Cicero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jash.2017.12.002_bib1","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1478-7954-10-22","article-title":"National, regional, and global trends in adult overweight and obesity prevalences","volume":"10","author":"Stevens","year":"2012","journal-title":"Popul Health Metr"},{"key":"10.1016\/j.jash.2017.12.002_bib2","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1017\/S0007114514002657","article-title":"Optimal cut-off values of BMI, waist circumference and waist: height ratio for defining obesity in Chinese adults","volume":"112","author":"Zeng","year":"2014","journal-title":"Br J Nutr"},{"key":"10.1016\/j.jash.2017.12.002_bib3","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/oby.20704","article-title":"Twelve-year weight change, waist circumference change and incident obesity: the Australian diabetes, obesity and lifestyle study","volume":"22","author":"Tanamas","year":"2014","journal-title":"Obesity"},{"key":"10.1016\/j.jash.2017.12.002_bib4","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1001\/jama.2016.6458","article-title":"Trends in obesity among adults in the United States, 2005 to 2014","volume":"315","author":"Flegal","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jash.2017.12.002_bib5","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0140-6736(14)60460-8","article-title":"Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"384","author":"Ng","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jash.2017.12.002_bib6","doi-asserted-by":"crossref","first-page":"e1000058","DOI":"10.1371\/journal.pmed.1000058","article-title":"The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors","volume":"6","author":"Danaei","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.jash.2017.12.002_bib7","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1161\/HYPERTENSIONAHA.108.113357","article-title":"Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004","volume":"52","author":"Cutler","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2017.12.002_bib8","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1161\/CIRCULATIONAHA.106.171016","volume":"113","author":"Poirier","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jash.2017.12.002_bib9","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1056\/NEJMc1513890","article-title":"Cardiometabolic risks and obesity in the young","volume":"374","author":"Borghi","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jash.2017.12.002_bib10","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1097\/HJH.0b013e32834a8a42","article-title":"Baseline predictors of resistant hypertension in the Anglo-Scandinavian Cardiac Outcome Trial (ASCOT): a risk score to identify those at high-risk","volume":"29","author":"Gupta","year":"2011","journal-title":"J Hypertens"},{"key":"10.1016\/j.jash.2017.12.002_bib11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/hr.2009.227","article-title":"Weight loss and blood pressure normalization: the relevance of early interventions in hypertension","volume":"33","author":"Cicero","year":"2010","journal-title":"Hypertens Res"},{"key":"10.1016\/j.jash.2017.12.002_bib12","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/hr.2009.220","article-title":"Effect of body weight loss and normalization on blood pressure in overweight non-obese patients with stage 1 hypertension","volume":"33","author":"Fogari","year":"2010","journal-title":"Hypertens Res"},{"key":"10.1016\/j.jash.2017.12.002_bib13","doi-asserted-by":"crossref","first-page":"386","DOI":"10.4062\/biomolther.2015.033","article-title":"Cardiovascular safety pharmacology of sibutramine","volume":"23","author":"Yun","year":"2015","journal-title":"Biomol Ther"},{"key":"10.1016\/j.jash.2017.12.002_bib14","first-page":"CD007654","article-title":"Long-term effects of weight-reducing drugs in people with hypertension","volume":"3","author":"Siebenhofer","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jash.2017.12.002_bib15","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jash.2017.12.002_bib16","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","year":"2009"},{"key":"10.1016\/j.jash.2017.12.002_bib17","series-title":"Comprehensive Meta-analysis Version 2","author":"Borenstein","year":"2005"},{"key":"10.1016\/j.jash.2017.12.002_bib18","series-title":"Methods for Meta-analysis in Medical Research","author":"Sutton","year":"2000"},{"key":"10.1016\/j.jash.2017.12.002_bib19","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.plipres.2015.08.003","article-title":"Effect of statin therapy on paraoxonase-1 status: a systematic review and meta-analysis of 25 clinical trials","volume":"60","author":"Ferretti","year":"2015","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.jash.2017.12.002_bib20","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/ptr.5045","article-title":"Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? Evidence from a meta-analysis","volume":"28","author":"Sahebkar","year":"2014","journal-title":"Phytother Res"},{"key":"10.1016\/j.jash.2017.12.002_bib21","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","article-title":"Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis","volume":"56","author":"Duval","year":"2000","journal-title":"Biometrics"},{"key":"10.1016\/j.jash.2017.12.002_bib22","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1345\/aph.1H234","article-title":"Low-dose orlistat effects on body weight of mildly to moderately overweight individuals: a 16 week, double-blind, placebo-controlled trial","volume":"40","author":"Anderson","year":"2006","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jash.2017.12.002_bib23","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/S0140-6736(09)61375-1","article-title":"Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study","volume":"374","author":"Astrup","year":"2009","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jash.2017.12.002_bib24","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.numecd.2006.03.004","article-title":"Orlistat increases serum paraoxonase activity in obese patients","volume":"17","author":"Audikovszky","year":"2007","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.jash.2017.12.002_bib25","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1097\/00004872-200211000-00026","article-title":"Orlistat improves blood pressure control in obese subjects with treated but inadequately controlled hypertension","volume":"20","author":"Bakris","year":"2002","journal-title":"J Hypertens"},{"key":"10.1016\/j.jash.2017.12.002_bib26","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.2337\/diacare.26.6.1667","article-title":"Lowering of LDL cholesterol rather than moderate weight loss improves endothelium-dependent vasodilatation in obese women with previous gestational diabetes","volume":"26","author":"Bergholm","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jash.2017.12.002_bib27","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1464-5491.2004.01474.x","article-title":"A randomized study of orlistat in combination with a weight management programme in obese patients with Type 2 diabetes treated with metformin","volume":"22","author":"Berne","year":"2005","journal-title":"Diabet Med"},{"key":"10.1016\/j.jash.2017.12.002_bib28","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1097\/00004872-200311000-00026","article-title":"Orlistat in hypertensive overweight\/obese patients: results of a randomized clinical trial","volume":"21","author":"Bloch","year":"2003","journal-title":"J Hypertens"},{"key":"10.1016\/j.jash.2017.12.002_bib29","first-page":"371","article-title":"Impact of weight loss on adipocytokines, C-reactive protein and insulin sensitivity in hypertensive women with central obesity","volume":"89","author":"Borges","year":"2007","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.jash.2017.12.002_bib30","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1742-1241.2002.tb11307.x","article-title":"Randomised trial of the effect of orlistat on body weight and cardiovascular disease risk profile in obese patients: UK Multimorbidity Study","volume":"56","author":"Broom","year":"2002","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.jash.2017.12.002_bib31","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0149-2918(03)80070-X","article-title":"Randomized, double-blind, placebo-controlled comparison of the action of orlistat, fluvastatin, or both an anthropometric measurements, blood pressure, and lipid profile in obese patients with hypercholesterolemia prescribed a standardized diet","volume":"25","author":"Derosa","year":"2003","journal-title":"Clin Ther"},{"key":"10.1016\/j.jash.2017.12.002_bib32","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1185\/030079904125004466","article-title":"The ORLIstat and CArdiovascular risk profile in patients with metabolic syndrome and type 2 DIAbetes (ORLICARDIA) Study","volume":"20","author":"Didangelos","year":"2004","journal-title":"Curr Med Res Opin"},{"issue":"5","key":"10.1016\/j.jash.2017.12.002_bib33","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1462-8902.2004.00359.x","article-title":"Effects of orlistat on obesity-related diseases - a six-month randomized trial","volume":"6","author":"Guy-Grand","year":"2004","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jash.2017.12.002_bib34","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1001\/archfami.9.2.160","article-title":"Orlistat in the long-term treatment of obesity in primary care settings","volume":"9","author":"Hauptman","year":"2000","journal-title":"Arch Fam Med"},{"issue":"Suppl 3","key":"10.1016\/j.jash.2017.12.002_bib35","first-page":"S24","article-title":"A one-year trial to assess the value of orlistat in the management of obesity","volume":"21","author":"James","year":"1997","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.jash.2017.12.002_bib36","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.2337\/diacare.25.6.1033","article-title":"Clinical efficacy of orlistat therapy in overweight and obese patients with insulin-treated type 2 diabetes: a 1-year randomized controlled trial","volume":"25","author":"Kelley","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jash.2017.12.002_bib37","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/j.1742-1241.2006.01052.x","article-title":"Effect of orlistat in overweight poorly controlled Chinese female type 2 diabetic patients: a randomised, double-blind, placebo-controlled study","volume":"60","author":"Kuo","year":"2006","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.jash.2017.12.002_bib38","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1365-2796.2000.00720.x","article-title":"The effect of orlistat on body weight and coronary heart disease risk profile in obese patients: the Swedish Multimorbidity Study","volume":"248","author":"Lindg\u00e4rde","year":"2000","journal-title":"J Intern Med"},{"key":"10.1016\/j.jash.2017.12.002_bib39","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.2337\/diacare.25.7.1123","article-title":"Effect of orlistat in overweight and obese patients with type 2 diabetes treated with metformin","volume":"25","author":"Miles","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jash.2017.12.002_bib40","first-page":"1","article-title":"Orlistat as an adjunct therapy in type 2 obese diabetic patients treated with sulphonylurea: a Bangladesh experience","volume":"30","author":"Pathan","year":"2004","journal-title":"Bangladesh Med Res Counc Bull"},{"key":"10.1016\/j.jash.2017.12.002_bib41","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1038\/sj.ijo.0802439","article-title":"Weight loss in obese Mexican Americans treated for 1-year with orlistat and lifestyle modification","volume":"27","author":"Poston","year":"2003","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.jash.2017.12.002_bib42","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1365-2796.2006.01702.x","article-title":"Evaluation of a primary care-oriented brief counselling intervention for obesity with and without orlistat","volume":"260","author":"Poston","year":"2006","journal-title":"J Intern Med"},{"key":"10.1016\/j.jash.2017.12.002_bib43","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0002-9149(00)01521-6","article-title":"Effect of orlistat-assisted weight loss in decreasing coronary heart disease risk in patients with syndrome X","volume":"87","author":"Reaven","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jash.2017.12.002_bib44","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2337\/dc06-0210","article-title":"Effect of orlistat on weight regain and cardiovascular risk factors following a very-low-energy diet in abdominally obese patients: a 3-year randomized, placebo-controlled study","volume":"30","author":"Richelsen","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jash.2017.12.002_bib45","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/oby.2000.8","article-title":"Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity. European Orlistat Obesity Study Group","volume":"8","author":"R\u00f6ssner","year":"2000","journal-title":"Obes Res"},{"key":"10.1016\/j.jash.2017.12.002_bib46","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0140-6736(97)11509-4","article-title":"Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group","volume":"352","author":"Sj\u00f6str\u00f6m","year":"1998","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jash.2017.12.002_bib47","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1463-1326.2004.00467.x","article-title":"Effect of orlistat on cardiovascular disease risk in obese adults","volume":"7","author":"Swinburn","year":"2005","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jash.2017.12.002_bib48","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1001\/archinternmed.2009.492","article-title":"A randomized trial of a low-carbohydrate diet vs orlistat plus a low-fat diet for weight loss","volume":"170","author":"Yancy","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jash.2017.12.002_bib49","first-page":"23","article-title":"Hazards of obesity\u2013the Framingham experience","volume":"723","author":"Higgins","year":"1988","journal-title":"Acta Med Scand Suppl"},{"issue":"Suppl 1","key":"10.1016\/j.jash.2017.12.002_bib50","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1467-789X.2007.00311.x","article-title":"Health risks associated with overweight and obesity","volume":"8","author":"Kopelman","year":"2007","journal-title":"Obes Rev"},{"key":"10.1016\/j.jash.2017.12.002_bib51","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/ijo.2014.111","article-title":"Is obesity predictive of cardiovascular dysfunction independent of cardiovascular risk factors?","volume":"39","author":"DeVallance","year":"2015","journal-title":"Int J Obes"},{"key":"10.1016\/j.jash.2017.12.002_bib52","doi-asserted-by":"crossref","first-page":"245","DOI":"10.7326\/M14-1753","article-title":"Cardiovascular mortality associated with 5 leading risk factors: national and state preventable fractions estimated from survey data","volume":"163","author":"Patel","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jash.2017.12.002_bib53","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s11883-014-0445-x","article-title":"Managing overweight and obesity in adults to reduce cardiovascular disease risk","volume":"16","author":"Ebbert","year":"2014","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.jash.2017.12.002_bib54","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1001\/jama.1996.03530440051036","article-title":"Blood pressure as a cardiovascular risk factor: prevention and treatment","volume":"275","author":"Kannel","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.jash.2017.12.002_bib55","doi-asserted-by":"crossref","first-page":"b1665","DOI":"10.1136\/bmj.b1665","article-title":"Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies","volume":"338","author":"Law","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jash.2017.12.002_bib56","doi-asserted-by":"crossref","first-page":"741","DOI":"10.4065\/84.8.741","article-title":"Primary and secondary prevention of cardiovascular diseases: a practical evidence-based approach","volume":"84","author":"O'Keefe","year":"2009","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jash.2017.12.002_bib57","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1751-7176.2008.00059.x","article-title":"Lifestyle changes and blood pressure control: a community-based cross-sectional survey (2006 Ontario survey on the prevalence and control of hypertension)","volume":"11","author":"Fodor","year":"2009","journal-title":"J Clin Hypertens"},{"key":"10.1016\/j.jash.2017.12.002_bib58","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1161\/HYPERTENSIONAHA.109.135178","article-title":"Long-term weight loss from lifestyle intervention benefits blood pressure: a systematic review","volume":"54","author":"Aucott","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2017.12.002_bib59","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s40292-015-0096-1","article-title":"Middle and long-term impact of a very low-carbohydrate ketogenic diet on Cardiometabolic factors: a multi-Center, cross-sectional, clinical study","volume":"22","author":"Cicero","year":"2015","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"10.1016\/j.jash.2017.12.002_bib60","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-2710.2011.01280.x","article-title":"Effects of 1-year orlistat treatment compared to placebo on insulin resistance parameters in patients with type 2 diabetes","volume":"37","author":"Derosa","year":"2012","journal-title":"J Clin Pharm Ther"}],"container-title":["Journal of the American Society of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933171117304151?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933171117304151?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T22:33:09Z","timestamp":1693348389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933171117304151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S1933171117304151"],"URL":"https:\/\/doi.org\/10.1016\/j.jash.2017.12.002","relation":{},"ISSN":["1933-1711"],"issn-type":[{"value":"1933-1711","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of orlistat on blood pressure: a systematic review and meta-analysis of 27 randomized controlled clinical trials","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Society of Hypertension","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jash.2017.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Society of Hypertension. All rights reserved.","name":"copyright","label":"Copyright"}]}}